Drug
LY2603618 clinical trials
Also written LY2603618.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2011 (4)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2011 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses LY2603618 is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study of Advanced or Metastatic Non-small Cell Lung CancerCompletedPhase 2Eli Lilly and CompanyNCT00988858Written as LY2603618
- A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid TumorsCompletedPhase 1Eli Lilly and CompanyNCT01341457Written as LY2603618
- C14 Study in Oncology Patients With Advanced and/or Metastatic Solid TumorsCompletedPhase 1Eli Lilly and CompanyNCT01296568Written as LY2603618
- A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of DesipramineCompletedPhase 1Eli Lilly and CompanyNCT01358968Written as LY2603618
- A Study in Non Small Cell Lung CancerCompletedPhase 1/2Eli Lilly and CompanyNCT01139775Written as LY2603618
- A Study for Participants With Pancreatic CancerCompletedPhase 1/2Eli Lilly and CompanyNCT00839332Written as LY2603618